Mankind Pharma Quarterly Results for Trading Insights
MANKIND • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹520 Cr
QSept 2025
Mankind Pharma Quarterly Results Key Highlights
- Revenue of ₹3,791 Cr in Sept 2025 (+13.7% vs Mar 2025, +19.5% vs Sept 2024)
- Net Profit of ₹520 Cr in Sept 2025 (+22.4% vs Mar 2025, -21.1% vs Sept 2024)
- EBITDA of ₹1,016 Cr in Sept 2025 (+8.9% vs Mar 2025)
- Operating Margin of 25.0% in Sept 2025 (+3.0pp vs Mar 2025)
- Earnings Per Share of ₹12.39 in Sept 2025 (+21.6% vs Mar 2025)
Mankind Pharma Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 3,791 | 3,333 | 3,653 | 3,173 | 2,517 | 13.7% | 19.5% |
| Net Profit (₹ Cr) | 520 | 425 | 445 | 659 | 477 | - | - |
| EBITDA (₹ Cr) | 1,016 | 933 | 930 | 956 | 681 | - | - |
| EPS (₹) | 12.39 | 10.19 | 10.62 | 16.31 | 11.76 | - | - |
| Operating Margin (%) | 25.0% | 22.0% | 24.0% | 28.0% | 24.0% | - | - |
Mankind Pharma Share Price Trend Around Quarterly Results
Visualize Mankind Pharma's 1-year price movement across quarterly results — ideal for logging trades in Mankind Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for Mankind Pharma
Additional stock information and data for MANKIND
Revenue Trend (₹ Cr)
Sept 2024
3,173
Jun 2025
3,653
Mar 2025
3,333
Sept 2025
3,791
Net Profit Trend (₹ Cr)
Sept 2024
659
Jun 2025
445
Mar 2025
425
Sept 2025
520
Operating Margin Trend (%)
Sept 2024
28.0%
Jun 2025
24.0%
Mar 2025
22.0%
Sept 2025
25.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Mankind Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.7 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6600.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.2 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4026.4 | 3,219 | 591 | +11.3% | - | 18.4% | 229.6 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1460.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1206.9 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores